These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7492766)
41. Pharmacokinetic and pharmacological profiles of free and liposomal recombinant human erythropoietin after intravenous and subcutaneous administrations in rats. Moriya H; Maitani Y; Shimoda N; Takayama K; Nagai T Pharm Res; 1997 Nov; 14(11):1621-8. PubMed ID: 9434284 [TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of [125I]-recombinant human interleukin-11: 2. Placental transfer and excretion into milk after subcutaneous administration to rats. Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S Eur J Drug Metab Pharmacokinet; 1998; 23(3):411-6. PubMed ID: 9842985 [TBL] [Abstract][Full Text] [Related]
43. Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions. Akahane K; Tojo A; Fukamachi H; Kitamura T; Saito T; Urabe A; Takaku F Exp Hematol; 1989 Feb; 17(2):177-82. PubMed ID: 2536329 [TBL] [Abstract][Full Text] [Related]
44. The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model. Bellizzi V; Sabbatini M; Fuiano G; Sansone G; Magri P; Uccello F; Andreucci M; De Nicola L; Cianciaruso B Nephrol Dial Transplant; 1998 Sep; 13(9):2210-5. PubMed ID: 9761499 [TBL] [Abstract][Full Text] [Related]
45. Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Zhou XJ; Vaziri ND Am J Physiol; 1992 Nov; 263(5 Pt 2):F812-5. PubMed ID: 1443172 [TBL] [Abstract][Full Text] [Related]
46. Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. Takeuchi M; Takasaki S; Miyazaki H; Kato T; Hoshi S; Kochibe N; Kobata A J Biol Chem; 1988 Mar; 263(8):3657-63. PubMed ID: 3346214 [TBL] [Abstract][Full Text] [Related]
47. Quantitative mapping of the N-linked sialyloligosaccharides of recombinant erythropoietin: combination of direct high-performance anion-exchange chromatography and 2-aminopyridine derivatization. Rice KG; Takahashi N; Namiki Y; Tran AD; Lisi PJ; Lee YC Anal Biochem; 1992 Nov; 206(2):278-87. PubMed ID: 1443598 [TBL] [Abstract][Full Text] [Related]
48. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells. Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865 [TBL] [Abstract][Full Text] [Related]
49. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver. Kato S; Ochiai N; Takano H; Io F; Takayama N; Koretsune H; Kunioka EI; Uchida S; Yamamoto K J Pharmacol Exp Ther; 2019 Dec; 371(3):675-683. PubMed ID: 31585986 [TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of erythropoietin in genetically anemic mice. Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298 [TBL] [Abstract][Full Text] [Related]
51. Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells. Sawyer ST; Krantz SB; Luna J Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3690-4. PubMed ID: 3035548 [TBL] [Abstract][Full Text] [Related]
52. [Overview of erythropoietin]. Lacombe C; Mayeux P; Casadevall N Nephrologie; 1991; 12(5):221-6. PubMed ID: 1662784 [TBL] [Abstract][Full Text] [Related]
53. Role of the kidney in the plasma clearance of angiotensinogen in the rat: plasma clearance and tissue distribution of 125I-angiotensinogen. Yayama K; Yoshiya M; Takahashi K; Matsui T; Takano M; Okamoto H Life Sci; 1995; 57(19):1791-801. PubMed ID: 7475921 [TBL] [Abstract][Full Text] [Related]
54. Systemic treatment with erythropoietin protects the neurovascular unit in a rat model of retinal neurodegeneration. Busch S; Kannt A; Kolibabka M; Schlotterer A; Wang Q; Lin J; Feng Y; Hoffmann S; Gretz N; Hammes HP PLoS One; 2014; 9(7):e102013. PubMed ID: 25013951 [TBL] [Abstract][Full Text] [Related]
55. Depression of stimulated erythropoietin production in mice with enhanced erythropoiesis. Lezón C; Alippi RM; Barceló AC; Martínez MP; Conti MI; Bozzini CE Haematologica; 1995; 80(6):491-4. PubMed ID: 8647512 [TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male rats. Woodruff TK; Krummen L; Chen SA; Lyon R; Hansen SE; DeGuzman G; Covello R; Mather J; Cossum P Endocrinology; 1993 Feb; 132(2):725-34. PubMed ID: 8425491 [TBL] [Abstract][Full Text] [Related]
57. Structure determination of the intact major sialylated oligosaccharide chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Watson E; Bhide A; van Halbeek H Glycobiology; 1994 Apr; 4(2):227-37. PubMed ID: 8054720 [TBL] [Abstract][Full Text] [Related]
58. Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Tan CC; Eckardt KU; Ratcliffe PJ Kidney Int; 1991 Jul; 40(1):69-76. PubMed ID: 1921157 [TBL] [Abstract][Full Text] [Related]
59. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Frede S; Fandrey J; Pagel H; Hellwig T; Jelkmann W Am J Physiol; 1997 Sep; 273(3 Pt 2):R1067-71. PubMed ID: 9321887 [TBL] [Abstract][Full Text] [Related]
60. Chemical Synthesis of an Erythropoietin Glycoform Having a Triantennary Maki Y; Okamoto R; Izumi M; Kajihara Y J Am Chem Soc; 2020 Dec; 142(49):20671-20679. PubMed ID: 33231436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]